(Q43803412)

27 November 2017

title

Rate and risk factors of liver toxicity in patients receiving antiretroviral therapy (English)

1 reference

27 November 2017

R Lana

1

1 reference

27 November 2017

M Núñez

series ordinal

2

1 reference

27 November 2017

J L Mendoza

series ordinal

3

1 reference

27 November 2017

V Soriano

series ordinal

4

1 reference

27 November 2017

language of work or name

Spanish

0 references

publication date

1 November 2001

1 reference

27 November 2017

1 reference

27 November 2017

volume

117

1 reference

27 November 2017

issue

16

1 reference

27 November 2017

page(s)

607-610

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

7 January 2021

HIV-protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Can HCV affect the efficacy of anti-HIV treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Correlates of hepatitis C virus infections among injection drug users.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations. Aquitaine Cohort, France, 1996-1998. Groupe dEpidémiologie Clinique de Sida en Aquitaine (GECSA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Interactions and Toxicities of Drugs Used in Patients with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Hepatotoxicity after introduction of highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Hepatitis C and HIV infection: biological, clinical, and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Severe hepatitis in three AIDS patients treated with indinavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

Severe hepatitis in patients with AIDS and haemophilia B treated with indinavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2972194-X

10.1016/S0025-7753(01)72194-X

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference